NVCR Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.22%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $28,167,448.79

NovoCure Insider Trading History Chart

NovoCure Share Price & Price History

^$56.44

▼ -2.3 (-3.92%)

As of 03/22/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

Click here now!

NovoCure Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/3/2023	Frank X Leonard	Insider	Sell	2,059	$77.64	$159,860.76	67,893
3/1/2023	Ashley Cordova	CFO	Sell	2,198	$76.36	$167,839.28	96,062
3/1/2023	Frank X Leonard	Insider	Sell	1,684	$76.36	$128,590.24	63,095
3/1/2023	Wilhelmus Cm Groenhuysen	COO	Sell	2,164	$76.36	$165,243.04	184,615
1/5/2023	Asaf Danziger	CEO	Sell	212,500	$108.74	$23,107,250.00	13,583
1/5/2023	Uri Weinberg	Insider	Sell	8,143	$116.14	$945,728.02	43,286
10/13/2022	Frank X Leonard	Insider	Sell	6,754	$76.01	$513,371.54	43,626
10/6/2022	Frank X Leonard	Insider	Sell	6,754	$84.37	$569,834.98	50,380
9/29/2022	Frank X Leonard	Insider	Sell	6,754	$77.35	$522,421.90	57,134
9/22/2022	Frank X Leonard	Insider	Sell	6,754	$77.00	$520,058.00	63,888
9/15/2022	Frank X Leonard	Insider	Sell	12,271	$88.52	$1,086,228.92	70,642
9/9/2022	Frank X Leonard	Insider	Sell	1,863	$88.00	$163,944.00	84,150
8/2/2022	Ely Benaim	Insider	Sell	437	$69.66	$30,441.42	34,631
8/2/2022	William F. Doyle	Chairman	Sell	837	$69.66	$58,305.42	551,176
6/10/2022	Jeryl L. Hilleman	Director	Sell	407	$69.61	$28,331.27	2,537
3/9/2022	Pritesh Shah	Insider	Sell	3,669	$71.19	$261,196.11
3/8/2022	Ashley Cordova	CFO	Sell	759	$70.10	$53,205.90
3/8/2022	Todd Christopher Longsworth	General Counsel	Sell	2,339	$70.10	$163,963.90
3/8/2022	Wilhelmus Cm Groenhuysen	COO	Sell	2,923	$70.10	$204,902.30
3/8/2022	William F. Doyle	Chairman	Sell	2,385	$70.10	$167,188.50
3/7/2022	Pritesh Shah	Insider	Sell	5,294	$69.55	$368,197.70
3/3/2022	Ashley Cordova	CFO	Sell	1,149	$74.50	$85,600.50
3/3/2022	Frank X Leonard	Insider	Sell	930	$74.50	$69,285.00
3/3/2022	Todd Christopher Longsworth	General Counsel	Sell	1,094	$74.50	$81,503.00
3/3/2022	Wilhelmus Cm Groenhuysen	COO	Sell	1,301	$74.50	$96,924.50
11/26/2021	Asaf Danziger	CEO	Buy	4,974	$102.44	$509,536.56
9/2/2021	Ashley Cordova	CFO	Sell	828	$138.23	$114,454.44
9/2/2021	Frank X. Leonard	Insider	Sell	540	$138.23	$74,644.20	74,013
9/2/2021	Wilhelmus Cm Groenhuysen	COO	Sell	181	$138.23	$25,019.63
8/12/2021	Ashley Cordova	CFO	Sell	26,624	$140.94	$3,752,386.56	45,993
8/5/2021	Martin J. Madden	Director	Sell	34	$153.13	$5,206.42
8/4/2021	Pritesh Shah	Insider	Sell	2,063	$148.71	$306,788.73	74,169
8/2/2021	Ely Benaim	Insider	Sell	536	$149.38	$80,067.68
7/30/2021	Ely Benaim	Insider	Sell	651	$158.96	$103,482.96
7/6/2021	Gabriel Leung	Director	Sell	1,000	$183.54	$183,540.00	73,859
6/10/2021	Pritesh Shah	Insider	Sell	23,540	$215.00	$5,061,100.00	77,732
6/7/2021	Gabriel Leung	Director	Sell	1,000	$204.55	$204,550.00	73,045
5/27/2021	Ely Benaim	Insider	Sell	1,833	$200.00	$366,600.00	30,887
5/10/2021	Ely Benaim	Insider	Sell	1,833	$189.65	$347,628.45	35,092
5/5/2021	Gabriel Leung	Director	Sell	1,000	$199.67	$199,670.00	73,045
5/5/2021	Pritesh Shah	Insider	Sell	1,290	$199.67	$257,574.30	101,272
4/13/2021	Asaf Danziger	CEO	Sell	97,973	$196.34	$19,236,018.82
4/13/2021	Ely Benaim	Insider	Sell	5,958	$200.00	$1,191,600.00	35,092
4/13/2021	Gabriel Leung	Director	Sell	6,000	$198.84	$1,193,040.00	78,045
4/13/2021	William F. Doyle	Chairman	Sell	95,000	$199.55	$18,957,250.00	648,993
4/1/2021	William F. Doyle	Chairman	Sell	7,928	$134.12	$1,063,303.36	658,321
2/28/2021	Wilhelmus Cm Groenhuysen	COO	Sell	3,670	$72.22	$265,047.40	150,014
1/15/2021	Todd Christopher Longsworth	General Counsel	Sell	63,814	$172.48	$11,006,638.72	123,474
12/21/2020	Ely Benaim	Insider	Sell	2,484	$156.71	$389,267.64	31,189
12/18/2020	Asaf Danziger	CEO	Sell	207,910	$157.39	$32,722,954.90	301,587
12/18/2020	Jeryl L. Hilleman	Director	Sell	2,500	$166.40	$416,000.00	3,400
11/2/2020	Ashley Cordova	CFO	Sell	230	$117.41	$27,004.30	26,212
9/25/2020	Uri Weinberg	Insider	Sell	15,250	$103.35	$1,576,087.50	36,347
9/17/2020	Wilhelmus Cm Groenhuysen	COO	Sell	12,500	$108.60	$1,357,500.00	144,540
9/15/2020	Wilhelmus Cm Groenhuysen	COO	Sell	50,868	$103.27	$5,253,138.36	155,107
9/14/2020	Gabriel Leung	Director	Sell	10,000	$95.00	$950,000.00	82,045
9/10/2020	Gabriel Leung	Director	Sell	10,000	$90.00	$900,000.00	81,159
9/9/2020	Pritesh Shah	Insider	Sell	28,321	$85.41	$2,418,896.61	71,165
9/2/2020	Gabriel Leung	Director	Sell	100	$85.00	$8,500.00	72,145
8/25/2020	Gabriel Leung	Director	Sell	7,112	$80.13	$569,884.56	79,157
7/31/2020	Ely Benaim	Insider	Sell	341	$76.39	$26,048.99
7/31/2020	William F. Doyle	Chairman	Sell	896	$76.39	$68,445.44	649,062
7/30/2020	Gabriel Leung	Director	Sell	7,112	$75.00	$533,400.00	79,157
7/22/2020	Gabriel Leung	Director	Sell	9,500	$67.03	$636,785.00	72,545
7/22/2020	Michael J. Ambrogi	COO	Sell	42,972	$67.02	$2,879,983.44	221,167
5/11/2020	Ely Benaim	Insider	Sell	1,611	$63.73	$102,669.03	16,822
5/11/2020	William F. Doyle	Chairman	Sell	31,332	$63.73	$1,996,788.36	649,958
5/6/2020	William F. Doyle	Chairman	Sell	29,881	$64.27	$1,920,451.87	628,047
5/4/2020	Pritesh Shah	Insider	Sell	1,184	$60.08	$71,134.72	103,026
4/14/2020	Michael J. Ambrogi	COO	Sell	27,519	$71.00	$1,953,849.00	243,622

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for NovoCure (NASDAQ:NVCR)

78.42% of NovoCure stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

NovoCure Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/7/2023	Nordwand Advisors LLC	1,515,000	$111.13M	13.5%	N/A	1.437%
3/6/2023	Rockefeller Capital Management L.P.	1,280	$93K	0.0%	-86.0%	0.001%
2/28/2023	Voya Investment Management LLC	320,335	$23.50M	0.0%	+8.7%	0.304%
2/21/2023	Macquarie Group Ltd.	80,249	$5.89M	0.0%	+13.2%	0.076%
2/17/2023	Truist Financial Corp	11,579	$0.85M	0.0%	+5.9%	0.011%
2/16/2023	Alliancebernstein L.P.	44,523	$3.27M	0.0%	+0.8%	0.042%
2/16/2023	United Capital Financial Advisers LLC	15,124	$1.11M	0.0%	+89.1%	0.014%
2/15/2023	CI Private Wealth LLC	3,020	$0.22M	0.0%	N/A	0.003%
2/15/2023	State of Wisconsin Investment Board	47,353	$3.47M	0.0%	-11.0%	0.045%
2/15/2023	Susquehanna Fundamental Investments LLC	52,266	$3.83M	0.1%	+16.9%	0.050%
2/15/2023	T. Rowe Price Investment Management Inc.	45,059	$3.31M	0.0%	N/A	0.043%
2/15/2023	Legal & General Group Plc	502,219	$36.84M	0.0%	-6.6%	0.479%
2/15/2023	Mariner LLC	6,252	$0.46M	0.0%	-4.9%	0.006%
2/15/2023	Nissay Asset Management Corp Japan ADV	10,506	$0.77M	0.0%	-2.2%	0.010%
2/15/2023	Norges Bank	973,653	$71.42M	0.0%	N/A	0.928%
2/15/2023	Fjarde AP Fonden Fourth Swedish National Pension Fund	23,400	$1.72M	0.0%	+1.3%	0.022%
2/15/2023	Algert Global LLC	5,371	$0.39M	0.0%	-19.9%	0.005%
2/15/2023	Allstate Investment Management Co.	3,956	$0.29M	0.0%	N/A	0.004%
2/15/2023	Caisse DE Depot ET Placement DU Quebec	12,000	$0.88M	0.0%	N/A	0.011%
2/14/2023	Vident Investment Advisory LLC	4,710	$0.35M	0.0%	+31.0%	0.004%
2/14/2023	Price T Rowe Associates Inc. MD	2,168,431	$159.05M	0.0%	-8.6%	2.066%
2/14/2023	Amundi	203,769	$19.70M	0.0%	+10.4%	0.194%
2/14/2023	Two Sigma Investments LP	3,000	$0.22M	0.0%	-93.9%	0.003%
2/14/2023	Qtron Investments LLC	4,894	$0.36M	0.1%	N/A	0.005%
2/13/2023	Advisors Asset Management Inc.	5,090	$0.37M	0.0%	-61.7%	0.005%
2/13/2023	Charles Schwab Investment Management Inc.	533,248	$39.11M	0.0%	+4.1%	0.508%
2/13/2023	Deutsche Bank AG	212,314	$15.57M	0.0%	-1.2%	0.202%
2/13/2023	Baird Financial Group Inc.	16,061	$1.18M	0.0%	+1.5%	0.015%
2/13/2023	Panagora Asset Management Inc.	12,102	$0.89M	0.0%	-4.7%	0.012%
2/13/2023	Barclays PLC	77,886	$5.71M	0.0%	-96.0%	0.074%
2/13/2023	Edgestream Partners L.P.	34,635	$2.54M	0.3%	+144.6%	0.033%
2/13/2023	The Manufacturers Life Insurance Company	73,789	$5.28M	0.0%	-3.9%	0.070%
2/13/2023	Geode Capital Management LLC	1,350,341	$98.93M	0.0%	+5.4%	1.287%
2/13/2023	American Century Companies Inc.	10,804	$0.79M	0.0%	-19.8%	0.010%
2/13/2023	M&T Bank Corp	3,761	$0.27M	0.0%	-21.2%	0.004%
2/13/2023	Korea Investment CORP	34,363	$2.52M	0.0%	-13.0%	0.033%
2/13/2023	Teacher Retirement System of Texas	10,620	$0.78M	0.0%	-21.3%	0.010%
2/13/2023	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	8,303	$0.61M	0.0%	-9.8%	0.008%
2/10/2023	Creative Planning	6,305	$0.46M	0.0%	N/A	0.006%
2/10/2023	Granite Investment Partners LLC	33,164	$2.43M	0.1%	+80.3%	0.032%
2/10/2023	Amalgamated Bank	23,789	$1.75M	0.0%	+0.7%	0.023%
2/10/2023	Sei Investments Co.	3,049	$0.22M	0.0%	-4.1%	0.003%
2/10/2023	Assetmark Inc.	6,484	$0.48M	0.0%	+14.1%	0.006%
2/10/2023	Sequoia Financial Advisors LLC	3,622	$0.27M	0.0%	N/A	0.003%
2/10/2023	Aviva PLC	200,430	$22.73M	0.1%	+151.9%	0.191%
2/10/2023	Franklin Resources Inc.	7,209	$0.53M	0.0%	+14.4%	0.007%
2/10/2023	Advisor Group Holdings Inc.	9,334	$0.68M	0.0%	-9.1%	0.009%
2/10/2023	Clearbridge Investments LLC	77,978	$5.72M	0.0%	-0.3%	0.074%
2/10/2023	Mitsubishi UFJ Trust & Banking Corp	239,734	$17.58M	0.0%	-40.5%	0.228%
2/10/2023	Vanguard Personalized Indexing Management LLC	3,528	$0.26M	0.0%	-53.4%	0.003%
2/10/2023	BNP PARIBAS ASSET MANAGEMENT Holding S.A.	110,642	$8.12M	0.0%	-3.8%	0.105%
2/10/2023	abrdn plc	33,009	$2.42M	0.0%	+4.1%	0.031%
2/9/2023	Intech Investment Management LLC	26,779	$1.96M	0.0%	+889.3%	0.026%
2/9/2023	First Trust Advisors LP	78,639	$5.77M	0.0%	+1,046.8%	0.075%
2/9/2023	Dimensional Fund Advisors LP	164,883	$12.09M	0.0%	+1.6%	0.157%
2/9/2023	Principal Financial Group Inc.	28,386	$2.08M	0.0%	+17.6%	0.027%
2/9/2023	Aviva PLC	200,430	$14.70M	0.1%	+151.9%	0.191%
2/9/2023	Treasurer of the State of North Carolina	44,844	$3.29M	0.0%	+1.3%	0.043%
2/9/2023	HighTower Advisors LLC	4,985	$0.36M	0.0%	-13.9%	0.005%
2/8/2023	Raymond James Financial Services Advisors Inc.	11,461	$0.84M	0.0%	+6.6%	0.011%
2/8/2023	Raymond James & Associates	16,554	$1.21M	0.0%	-6.4%	0.016%
2/8/2023	Fiera Capital Corp	324,630	$23.81M	0.1%	-2.0%	0.309%
2/8/2023	Cambridge Investment Research Advisors Inc.	5,057	$0.37M	0.0%	-5.8%	0.005%
2/8/2023	Van ECK Associates Corp	16,377	$1.20M	0.0%	+21.0%	0.016%
2/8/2023	California Public Employees Retirement System	228,653	$16.77M	0.0%	+9.2%	0.218%
2/8/2023	Nordea Investment Management AB	5,496	$0.39M	0.0%	-15.0%	0.005%
2/8/2023	Swiss National Bank	383,100	$28.10M	0.0%	-5.9%	0.365%
2/8/2023	Russell Investments Group Ltd.	38,715	$2.79M	0.0%	+1.1%	0.037%
2/8/2023	Arizona State Retirement System	26,682	$1.96M	0.0%	+3.2%	0.025%
2/7/2023	State Board of Administration of Florida Retirement System	118,070	$8.66M	0.0%	-3.0%	0.113%
2/7/2023	Duality Advisers LP	30,980	$2.27M	0.3%	+392.0%	0.030%
2/7/2023	Commonwealth Equity Services LLC	7,745	$0.57M	0.0%	+11.5%	0.007%
2/7/2023	LPL Financial LLC	24,836	$1.82M	0.0%	+12.0%	0.024%
2/7/2023	Handelsbanken Fonder AB	15,523	$1.14M	0.0%	+2.6%	0.015%
2/7/2023	Envestnet Asset Management Inc.	24,088	$1.77M	0.0%	+12.9%	0.023%
2/7/2023	TD Asset Management Inc	109,180	$8.01M	0.0%	-12.6%	0.104%
2/7/2023	Oppenheimer Asset Management Inc.	3,924	$0.29M	0.0%	-9.6%	0.004%
2/7/2023	Robeco Institutional Asset Management B.V.	7,942	$0.58M	0.0%	+712.9%	0.008%
2/6/2023	Daiwa Securities Group Inc.	11,228	$0.82M	0.0%	-3.6%	0.011%
2/6/2023	Brinker Capital Investments LLC	10,606	$0.78M	0.0%	+3.2%	0.010%
2/6/2023	Hartline Investment Corp	304,482	$22.33M	5.1%	N/A	0.290%
2/6/2023	Banque Pictet & Cie SA	60,407	$4.43M	0.0%	+97.2%	0.058%
2/6/2023	Asset Management One Co. Ltd.	53,837	$3.85M	0.0%	-6.2%	0.051%
2/6/2023	Taylor Frigon Capital Management LLC	42,061	$3.09M	1.7%	-6.4%	0.040%
2/2/2023	SG Americas Securities LLC	8,415	$0.62M	0.0%	-66.7%	0.008%
2/2/2023	Nisa Investment Advisors LLC	8,416	$0.62M	0.0%	-11.2%	0.008%
2/2/2023	ProShare Advisors LLC	10,049	$0.74M	0.0%	-1.9%	0.010%
2/1/2023	Bank of Montreal Can	13,154	$0.98M	0.0%	-36.3%	0.013%
2/1/2023	State of New Jersey Common Pension Fund D	58,026	$4.26M	0.0%	+3.5%	0.055%
2/1/2023	CWM LLC	2,079	$0.15M	0.0%	+12.9%	0.002%
1/30/2023	New York State Common Retirement Fund	213,585	$15.67M	0.0%	+1.4%	0.204%
1/30/2023	Sumitomo Mitsui Trust Holdings Inc.	266,644	$19.56M	0.0%	-1.3%	0.254%
1/27/2023	Nordwand Advisors LLC	9,114,361	$668.54M	29.3%	N/A	8.684%
1/26/2023	Strs Ohio	11,051	$0.81M	0.0%	N/A	0.011%
1/26/2023	Harel Insurance Investments & Financial Services Ltd.	820	$60K	0.0%	-12.8%	0.001%
1/25/2023	Fifth Third Bancorp	3,235	$0.24M	0.0%	+38.3%	0.003%
1/25/2023	Whittier Trust Co.	740	$54K	0.0%	N/A	0.001%
1/25/2023	Lindbrook Capital LLC	50,354	$3.69M	0.5%	+29,346.8%	0.048%
1/24/2023	Baillie Gifford & Co.	8,863,842	$650.16M	0.7%	-0.6%	8.405%
1/24/2023	Xponance Inc.	14,002	$1.03M	0.0%	+14.5%	0.013%

Data available starting January 2016

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.

Today's Range

Now: $56.44

$56.35

$58.70

50 Day Range

MA: $81.57

$56.44

$95.70

52 Week Range

Now: $56.44

$56.35

$120.03

Volume

612,688 shs

Average Volume

1,103,196 shs

Market Capitalization

$5.95 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.83

Who are the company insiders with the largest holdings of NovoCure?: NovoCure's top insider investors include:
William F Doyle (Chairman)
Wilhelmus Cm Groenhuysen (COO)
Pritesh Shah (Insider)
Ashley Cordova (CFO)
Frank X Leonard (Insider)
Gabriel Leung (Director)
Frank X Leonard (Insider)
Uri Weinberg (Insider)
Ely Benaim (Insider)
Asaf Danziger (CEO)
Jeryl L Hilleman (Director)
Martin J Madden (Director)
Todd Christopher Longsworth (General Counsel)
Learn More about top insider investors at NovoCure.
Who are the major institutional investors of NovoCure?: NovoCure's top institutional shareholders include:
Nordwand Advisors LLC — 8.68%
Baillie Gifford & Co. — 8.40%
Price T Rowe Associates Inc. MD — 2.07%
Nordwand Advisors LLC — 1.44%
Geode Capital Management LLC — 1.29%
Norges Bank — 0.93%
Learn More about top institutional investors of NovoCure stock.
Which major investors are selling NovoCure stock?: In the last quarter, NVCR stock was sold by these institutional investors:
Barclays PLC
Price T Rowe Associates Inc. MD
Mitsubishi UFJ Trust & Banking Corp
Group One Trading L.P.
Baillie Gifford & Co.
Two Sigma Investments LP
Citigroup Inc.
Legal & General Group Plc
Within the last year, company insiders that have sold NovoCure company stock include:
William F Doyle (Chairman)
Wilhelmus Cm Groenhuysen (COO)
Pritesh Shah (Insider)
Ashley Cordova (CFO)
Frank X Leonard (Insider)
Gabriel Leung (Director)
Frank X Leonard (Insider)
Uri Weinberg (Insider)
Learn More investors selling NovoCure stock.
Which major investors are buying NovoCure stock?: In the last quarter, NVCR stock was acquired by institutional investors including:
Nordwand Advisors LLC
Nordwand Advisors LLC
Norges Bank
Hartline Investment Corp
Bank of America Corp DE
Point72 Asset Management L.P.
Millennium Management LLC
Aviva PLC

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

NVCR Insider Trading

NovoCure Insider Trading History Chart

NovoCure Share Price & Price History

NovoCure Insider Trading History

SEC Filings (Institutional Ownership Changes) for NovoCure (NASDAQ:NVCR)

Institutional Buying and Selling by Quarter

NovoCure Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of NovoCure?

Who are the major institutional investors of NovoCure?

Which major investors are selling NovoCure stock?

Which major investors are buying NovoCure stock?